(Q45790760)

16 December 2017

title

Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment (English)

1 reference

16 December 2017

1 reference

1 reference

M R Narkewicz

1

1 reference

16 December 2017

D Smith

2

1 reference

16 December 2017

A Silverman

3

1 reference

16 December 2017

J Vierling

4

1 reference

16 December 2017

R J Sokol

5

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

16 December 2017

The Journal of Pediatrics

published in

1 reference

16 December 2017

volume

127

1 reference

16 December 2017

issue

5

1 reference

16 December 2017

page(s)

815-818

1 reference

16 December 2017

Interferon in the management of chronic hepatitis B.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Interferon alfa-2b therapy in children with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

The value of quantitative measurement of HBeAg and HBsAg before interferon-alpha treatment of chronic hepatitis B in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Chronic active hepatitis B infection in Romanian adoptees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Pediatric HBsAg chronic liver disease and adult asymptomatic carrier status: two stages of the same entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970181-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(95)70181-8

1 reference

16 December 2017

1 reference

16 December 2017